Saved source record
A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes
This is a source-metadata record last found in a complete check on Sep 28, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.
Source status: Exact-ID ClinicalTrials.gov record checked Sep 28, 2026. A results section was present in that response.
Study metadata
- Study type
- Trial results posted
- Study category (metadata hint)
- Human
- Source date
- Results posted: 2022-02-14
- Authors
- Not reported in source metadata
- Journal or registry
- ClinicalTrials.gov
- Registry study design
- INTERVENTIONAL
- Registry enrollment
- 1879 (actual)
- Funding agencies
- Not reported in source metadata
- Identifiers
- NCT: NCT03987919
- First found
- Sep 28, 2026
- Last found
- Sep 28, 2026
Original sources
Browse saved studies · Search live sources